Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13134451 | 0.88 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL13134458 | 0.85 | ALDH1A1 (0.34) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL13765460 | 0.81 | MEN1 (0.32) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL16318225 | 0.80 | ALDH1A1 (0.33) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL13765456 | 0.80 | ALDH1A1 (0.36) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL16318255 | 0.78 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL13765488 | 0.77 | ALDH1A1 (0.31) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL13134455 | 0.74 | PRKCA (0.36) | — | |
| SCHEMBL13134453 | 0.73 | ALDH1A1 (0.41) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL13020530 | 0.73 | MMP8 (0.41) | MEN1KMT2AALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009086192-A1 | BIODEGRADABLE PHOSPHATE PROTECTED NUCLEOTIDE DERIVATIVES AND THEIR USE AS CANCER, ANTI VIRAL AND ANTI PARASITIC AGENTS | ALIOS BIOPHARMA, INC. (US) | 2009-07-09 | — | — | WO | disclosed |